Japan IP court rules Amgen's patent claims fall short in clash with Sanofi
Amgen has lost a significant battle in its long‑running patent dispute with Sanofi’s Japanese subsidiary. The Japan Intellectual Property High Court dismissed Amgen’s appeal, ruling that its patents for neutralizing antibodies...To view the full article, register now.
Already a subscriber? Click here to view full article